Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Lori Wood
- Study ID
- NCT05659524
- Status
- Recruiting
Conditions
- Pituitary Tumor
Eligibility Criteria
- Sex
- ALL
- Age
- 19 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- Nasal saline irrigation — OTHERThe following nasal care recommendations have been approved by the study protocol committee for patients randomized to the treatment arm with saline irrigations: * Postoperative days 1 through 3: patients will administer saline spray (e.g., Ocean nasal spray) to both nostrils four times daily. * Postoperative day 3 to week 12: patients will begin twice daily sinus irrigation rinse (e.g., NeilMed Sinus Rinse). They will perform 240 mL sinus rinses BID. After day 30, patients will perform sinus irrigation as needed. If a patient is unable to tolerate nasal rinses, saline spray can be used as an alternative.
Study Details
This is a prospective, single-blinded, multicenter study evaluating the benefit of sinonasal irrigations following endoscopic pituitary surgery. The goal of this study is to create practice changing guidelines with objective data highlighting the importance of irrigations on postoperative outcomes for pituitary surgery.
Key Dates
- Start date
- Dec 18, 2020
- Status verified
- Apr 2024
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 140 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Active Comparator: Nasal saline irrigationPatients randomized to standard postoperative nasal care with twice a day saline sinonasal irrigations
- No Intervention: No InterventionPatients randomized to not performing saline sinonasal irrigations.
Primary Outcome Measure
Difference in mean sinonasal quality of life [ Time Frame: 12 weeks ]
Central Contacts
- Val Calores602-406-8772
- Malika Bhargava602-406-7121
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Barrow Neurological Institute at St. Joseph's Hospital and Medical Center | Phoenix | Arizona | 85013 | Andrew Little, MD (PRINCIPAL_INVESTIGATOR) Griffith Santarelli, MD (SUB_INVESTIGATOR) |
| Cleveland Clinic | Cleveland | Ohio | 44195 | Varun Kshettry, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Phoenix, AZ
Related Studies
- Pituitary Tumor Surveillance: Pathogenic CorrelationRecruiting · Cedars-Sinai Medical Center · Los Angeles, California
- Evaluation of the CONVIVO SystemRecruiting · Dartmouth-Hitchcock Medical Center · Lebanon, New Hampshire